• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 726-732.DOI: 10.3969/j.issn.1671-2587.2026.05.009

• 临床输血 • 上一篇    下一篇

基于“三步法”识别流程鉴定红细胞意外抗体特异性的初步研究*

丁梦圆1, 林昊2, 冯金哲3, 温会燕4   

  1. 1苏州市中心血站配型室,江苏苏州 215006;
    2苏州市妇幼保健院输血科,江苏苏州 215006;
    3苏州市立医院输血科,江苏苏州 215006;
    4苏州大学附属第二医院输血科,江苏苏州 215006
  • 收稿日期:2026-09-01 修回日期:2026-09-23 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 温会燕,主要从事输血医学研究,(E-mail)wenhuiyan2012@163.com。共同通信作者:冯金哲,主要从事输血医学研究,(E-mail)182287621@qq.com。
  • 作者简介:丁梦圆,主要从事输血医学研究,(E-mail)mengyuan60_09@sina.com。并列第一作者:林昊,主要从事输血医学研究,(E-mail)254457255@qq.com。
  • 基金资助:
    *本课题受苏州市科技攻关计划项目(No.SYWD2025123)、苏州市预防医学会科技项目(No.SZSYFYXH-KJ-ZD2026-29)资助

Preliminary Study on Identification of Red Blood Cell Unexpected Antibody Specificity Based on the "Three-Step Method" Identification Process

DING Mengyuan1, LIN Hao2, FENG Jinzhe3, WEN Huiyan4   

  1. 1Blood Group Reference Laboratory, Suzhou Blood Center, Suzhou 215006;
    2Department of Transfusion Medicine, Suzhou Maternal and Child Health Hospital, Suzhou 215006;
    3Department of Transfusion Medicine, Suzhou Municipal Hospital, Suzhou 215006;
    4Department of Transfusion Medicine, The Second Affiliated Hospital of Soochow University, Suzhou 215006
  • Received:2026-09-01 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

摘要: 目的 分析红细胞意外抗体筛查阳性但抗体鉴定阴性或无特异性的主要原因,探索一套能够提高特异性抗体检出率、减少无效标本送检的检验流程。方法 收集2024年11月25日—2026年2月5日参比实验室接收的抗体筛查阳性标本,562例完成抗体鉴定的标本中有119例(21.17%)阴性或无特异性者,选取其中50例进行详细原因调查;将4例已知特异性抗体标本分发至4家医院进行多中心比对,并统一抗体筛查细胞及抗人球蛋白卡以控制变量。另取7例血清标本(含1例抗-E弱阳性对照),持续监测同一批抗体筛查细胞储存第5~15周的凝集强度变化,采用混合效应模型(REML)与Kaplan-Meier法分析。基于成因调查结果设计“三步法”识别流程,在2家医院试运行2个月,试运行期间17例送检标本为干预组(依从7例),以2024年同期12例为历史对照,比较特异性抗体检出率。结果 50例标本中,抗筛细胞假阳性、盐水抗体、弱抗体及AUS为主要成因,部分标本检出HLA抗体。多中心比对显示,冷反应性抗-M仅在实验室1检出,统一使用抗人球蛋白卡后冷凝集素及抗-M均未检出。7例监测标本凝集强度随储存时间延长显著升高[F(8,42)=11.35,P<0.000 1],第12周(P=0.000 5)、第13周(P=0.030 9)、第14周(P<0.000 1)、第15周(P=0.025 7)均显著高于第5周基线;15周内7例全部发生假阳性事件,中位发生时间为12周。试运行期间,依从组特异性抗体检出率为100%(7/7),不依从组为70%(7/10),绝对风险差30%(95%CI:2%—58%,P=0.237);干预组弱阳性标本比例(64.7%)显著高于历史对照组(16.7%,P=0.021)。结论 抗筛细胞储存期延长所致假阳性是抗体鉴定无特异性的重要可干预因素,储存≥12周后假阳性风险显著增加;“三步法”识别流程可提高特异性抗体检出率,将抗筛细胞功能状态纳入日常质控有助于减少假阳性干扰。

关键词: 抗体筛查, 抗体鉴定, 假阳性反应, 储存时间, 抗筛细胞

Abstract: Objective To analyze the major causes of positive unexpected antibody screening with negative or nonspecific identification, and to develop a workflow that improves specific alloantibody detection while reducing unnecessary referrals. Methods We examined antibody screening-positive specimens referred to a reference laboratory from November 25, 2024 to February 5, 2026. Of 562 specimens completing antibody identification, 119 (21.17%) yielded negative or nonspecific results, and 50 were selected for detailed etiological investigation. Four specimens with known antibody specificity were sent to four hospital laboratories for multicenter comparison with screening cells and anti-human globulin cards unified to control variables. Seven sera, including one weak anti-E positive control, were tested weekly to monitor agglutination intensity of the same batch of screening cells stored from weeks 5 to 15; data were analyzed using a mixed-effects model (REML) and Kaplan-Meier method. Based on these findings, a three-step identification protocol was piloted in two hospitals for 2 months. Seventeen referred specimens (7 compliant) formed the intervention group, and 12 specimens from the same period of the previous year served as historical controls to compare the detection rate of specific antibodies. Results Among the 50 specimens, the main causes were false-positive screening cells, saline-reactive antibodies, weak alloantibodies and antibodies of undetermined specificity (AUS); HLA antibodies were detected in some cases. In the multicenter comparison, cold-reactive anti-M was detected only in laboratory 1, and after unified use of the anti-human globulin card, neither cold agglutinin nor anti-M was detected. Agglutination intensity of the 7 monitored specimens increased significantly with prolonged storage [F (8,42)=11.35, P<0.000 1], and was significantly higher at weeks 12 (P=0.000 5), 13 (P=0.030 9), 14 (P<0.000 1) and 15 (P=0.025 7) than at week 5. All 7 specimens developed false-positive events within 15 weeks (median, 12 weeks). During the pilot, specific antibody detection was 100% (7/7) in the compliant group versus 70% (7/10) in the non-compliant group(absolute risk difference 30%, 95%CI: 2%—58%, P=0.237). Weak-positive specimens were more frequent in the intervention group than in historical controls (64.7%) vs 16.7%, P=0.021). Conclusion sStorage-related false positivity of screening cells is an important modifiable cause of nonspecific antibody identification, especially after ≥12 weeks of storage. The three-step protocol can improve specific antibody detection. Incorporating screening cell functional status into routine quality control may reduce false-positive interference.

Key words: Antibody screening, Antibody identification, False-positive reactions, Storage time, Antibody screening cells

中图分类号: